Supernus Pharmaceuticals

$0.00 (0.00%) As of 12:00 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.

About SUPN

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products.

CEO
Jack A. Khattar
Employees
575
Headquarters
Rockville, Maryland
Founded
2005

SUPN Key Statistics

Market cap
1.57B
Price-Earnings ratio
22.71
Dividend yield
—
Average volume
346.84K
High today
$29.45
Low today
$28.46
Open price
$28.81
Volume
326.39K
52 Week high
$34.50
52 Week low
$23.15

SUPN Earnings

$0.00
$0.19
$0.38
$0.57
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure